Glycosyl-etoposide prodrugs, a process for preparation...

Details Glycosyl-etoposide prodrugs, a process for preparation... Glycosyl-etoposide prodrugs, a process for preparation...

2007-07-10

2007-07-10

Celsa, Bennett (Department: 1639)

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Preparing compound containing saccharide radical

C536S016800

Reexamination Certificate

active

10128493

ABSTRACT:
The present invention relates to glycosyl-etoposide prodrugs, a process for the preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates for treating cancers.

REFERENCES:
patent: 3524844 (1970-08-01), Keller-Juslen et al.
patent: 4547567 (1985-10-01), Umezawa et al.
patent: 4727136 (1988-02-01), Jennings et al.
patent: 4757138 (1988-07-01), Fujii et al.
patent: 4935504 (1990-06-01), Saulnier et al.
patent: 4975278 (1990-12-01), Senter et al.
patent: 5036055 (1991-07-01), Ohnuma et al.
patent: 5041424 (1991-08-01), Saulnier et al.
patent: 5045451 (1991-09-01), Uhr et al.
patent: 5057313 (1991-10-01), Shih et al.
patent: 5106951 (1992-04-01), Morgan, Jr. et al.
patent: 5122368 (1992-06-01), Greenfield et al.
patent: 5164311 (1992-11-01), Gupta
patent: A 2025899 (1990-07-01), None
patent: 0 3826562 (1988-02-01), None
patent: A3909799.4 (1990-07-01), None
patent: 0 141 079 (1985-05-01), None
patent: A 0172 045 (1986-02-01), None
patent: 0 302 473 (1989-02-01), None
patent: 0 352 761 (1990-01-01), None
patent: DE388 914 (1990-09-01), None
patent: 0423747 (1991-04-01), None
patent: A 2 591 895 (1987-06-01), None
patent: 63-192793 (1988-08-01), None
patent: WO 88/07378 (1988-10-01), None
patent: WO A 908770 (1991-06-01), None
Fleminger et al., “Oriented Immobilization of Periodate-Oxidized Monoclonal Antibodies on Amino and Hydrazide Derivatives of Eupergit C,” Applied Biochem. Biotechnol., vol. 23, pp. 132-137 (1990).
Kashimata et al., Experientia, vol. 43, pp. 191-192 (1987).
Shcröder et al., The Peptides, vol. I, pp. xxii-xxiii (1965).
Chatterjee et al., “Idiotypic Antibody Immunotherapy of Cancer,” Cancer Immunol. Immunother., Chapter 38: 75-82 (1994).
W.J. Harris et al., “Therapeutic Antibodies—The Coming Of Age,” Tibtech, vol. 11, pp. 42-44 (1993).
L. Riechmann et al., “Reshaping Human Antibodies for Therapy,” Nature, vol. 332, pp. 323-327 (1986).
S. Morrison, “Transfectomas Provide Novel Chimeric Antibodies,” Science, vol. 229, pp. 1202-1207 (1985).
Washington Post, “Prostate Cancer Blood Test Surpasses Traditional Physical Exam in Study,” (Aug. 25, 1993).
Dillman, Ann. Internal Medicine, vol. 111, No.7, pp. 592-603 (1989).
Borrebaeck, J. Immunolog. Meth., vol. 123, pp. 157-165 (1989).
Osband et al., Immunology Today, vol. 11, No. 6, pp. 193-195 (1990).
Waldmann, Science, vol. 252, pp. 1657-1662 (1991).
Martin et al., Cancer Research, vol. 46, pp. 2189-2192 (1986).
Chaudhary et al., Proc. Natl. Acad. Sci. USA, vol. 84, pp. 4538-4542 (1987).
Gregoriadis et al., Tibtech, vol. 11, p. 440-442 (1993).
A. H. Blair et al., “Linkage of Cytotoxic Agents to Immunoglobulins,” J. Immunolog. Meth., vol. 59, pp. 129-143 (1983).
T. I. Ghose et al., “Preparation of Antibody-Linked Cytotoxic Agents,” Meth. Enzymol., vol. 93, pp. 280-333 (1983).
K. J. Dean et al., “Studies on Human Liver α-Galactosidases: Purification of α-Galactosidase A and its Enzymatic Properties with Glycolipid and Oligosaccharide Substrates,” J. Biol. Chem., vol. 254, pp. 9994-10000 (1979).
K. Ho., “Human β-glucuronidase. Studies on the Effects of pH and Bile Acids in Regard to Its Role in the Pathogenesis of Cholelithiasis,” Biochim. Biophys. Acta, vol. 827, pp. 197-206 (1985).
G. Dawson et al., Substrate Specificity of Human α-Fucosidase, Arch. Biochem. Biophys., vol. 184, pp. 12-23 (1877).
C. Noeske et al., “β-D-Mannosidase from Human Placenta: Properties and Partial Purification,” Hoppe-Seyler's Z. Physiol. Chem., vol. 364, pp. 1645-1651 (1983).
N.-G. Asp et al., “Acid α-Glucosidase from Human Gastrointestinal Mucosa-Separation and Characterization,” Scand. J. Clin. Lab. Invest., vol. 33, pp. 239-245 (1974).
A. Orlacchio et al., “α-N-Acetyl-D-glucosaminidase Isoenzymes from Human Amnionic Membranes,” Clin. Chim. Acta, vol. 159, pp. 279-289 (1986).
F. Furbish et al., “Enzyme replacement therapy in Gaucher's disease: Large-scale purification of glucocerebrosidase suitable for human administration,” Proc. Natl. Acad. Sci. USA, vol. 74, No. 8, pp. 3560-3563 (1977).
W. Rohrborn et al., “Human Placenta α-N-Acetylglucosaminidase: Purification, Characterization and Demonstration of Multiple Recognition Forms,” Hoppe-Seyler's Z. Physiol. Chem. vol. 359, pp. 1353-1362 (1978).
R. Salvayre et al., “α-Galactosidases et α-N-Acetylgalactosaminidase Bases Biochimigues de la Maladle de Fabry,” Pathol. Biol., vol. 32, pp. 269-284 (1984). (Abstract only).
G. A. Grabowski et al., “Comparative Physical, Kinetic and Immunologic Properties of the Acidic and Neutral α-D-Mannosidase Isozymes from Human Liver,” Enzyme, vol. 25, pp. 13-25 (1980).
K. Hande et al., “Metabolism and Excretion of Etoposide in Isolated, Perfused Rat Liver Models,” Cancer Research, vol. 48, No. 20, pp. 5692-5695, Oct. 15, 1988.
K. Hande et al., “Identification of Etoposide Glucuronide as a Major Metabolite of Etoposide in the Rat and Rabbit,” Cancer Res., vol. 48, No. 7, pp. 1829-1834, (1988).
J.J.M. Holthuis et al., “Determination of the Glucuronide(s) of the Antineoplastic Agents Etoposide,” Methodological Surveys in Biochemistry Anal., vol. 16 (Bioactive Analytes, Inc., CNS Drugs, Peptides and Enantiomers), pp. 389-393.
Hermentin et al., “Investigations with Monoclonal Antibody Drug (Anthracycline) Conjugates,” Behring Inst. Mitt., No. 82, 197-215 (1988).
Righetti et al., “Biochemical and Clinical Applications of Isoelectric Focusing,” Elsevier Scientific Publ. Co. (1979).
Horsfall et al., “Purification of Human Autoantibodies from Cross-Linked Antigen Immunosorbents,” J. Immunolog. Meth., vol. 104, pp. 43-49 (1987).
Towbin et al., “Electrophoretic Transfer of Proteins from Polyacrylamide Gels to Nitrocellulose Sheets: Procedure and Some Applications,” Proc. Natl. Acad. Sci. USA vol. 76, pp. 4350-4354 (1979).
Oshima et al., “Cloning, Sequencing, and Expression of cDNA for Human β-Glucuronidase,” Proc. Natl. Acad. Sci. USA, vol. 84, pp. 685-689 (1987).
Bosslet et al., “Quantitive Considerations Supporting the Irrelevance of Circulating Serum CEA for the Immunoscintigraphic Visualization of CEA Expressing Carcinomas,” Eur. J. Nucl. Med., vol. 14, pp. 523-528 (1988).
Walter et al., “Anti-Idiotypic Antibodies: Powerful Tools in Diagnosis and Therapy,” Behring Inst. Mitt., vol. 82, pp. 182-192 (1988).
Seemann, G., et al., “Antibody Enzyme Fusion Protein for Antibody Directed Enzyme Prodrug Therapy-Carcinoembryonic Antigen-Specific Monoclonal Antibody and β-Glucuronidase Fusion Protein,” Biotechnology Abstracts, Abstract No. 92-14076 (1991).
Daniels et al., “Purification and Characterization of a Cytosolic Broad Specificity β-Glucosidase from Human Liver,” J. Biol. Chem., vol. 256, pp. 13004-13013 (1981).
W.R. Clark, “The Experimental Foundations of Modern Immunology”, pp. 458-462.
M. Gerken et al., “Glycosyl Prodrugs of Anthracyclines, A Process for the Preparation Thereof and the Use Thereof in Combination with Functionalized Tumor-Specific Enzyme Conjugates,” Abstract, Australian Patent Application No. AU-A-70117/91 (1991).
Cunningham et al., “Antibody Engineering-How To Be Human,” Tibtech, vol. 10 (1992).
Cordell et al., “Immunoenzymatic Labeling of Monoclonal Antibodies Using Immune Complexes of Alkaline Phosphatase and Monoclonal Anti-Alkaline Phosphatase (APAAP Complexes),” J. Histochem. Cytochem., vol. 32, pp. 219-229 (1984).
Stahl et al., “Evidence for Specific Recognition Sites Mediating Clearance of Lysosomal Enzymes in vivo,” Proc. Natl. Acad. Sci. USA, vol. 76, No. 11, pp. 4045-4049 (1976).

Affiliated with

Also associated with

Rating

Glycosyl-etoposide prodrugs, a process for preparation... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glycosyl-etoposide prodrugs, a process for preparation..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycosyl-etoposide prodrugs, a process for preparation... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3759600